Maharashtra, India

Jitendra Patil

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Glenmark Pharmaceuticals Limited. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jitendra Patil: Innovator in Respiratory Treatment

Introduction

Jitendra Patil is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of respiratory medicine through his innovative work on metered dose inhalers. His dedication to improving patient care is evident in his patented inventions.

Latest Patents

Jitendra Patil holds a patent for a metered dose inhaler designed for ipratropium bromide solution. This invention relates to a device that comprises a stable inhalable composition of ipratropium bromide, contained in a canister fitted with a metering valve, an actuator, and a dose indicator. The patent also details a process for preparing this pharmaceutical composition, which is used in the treatment of respiratory disorders, particularly for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Career Highlights

Jitendra Patil is currently associated with Glenmark Pharmaceuticals Limited, where he continues to work on innovative solutions for respiratory health. His expertise and commitment to research have positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Some of his coworkers include Ulhas R Dhuppad and Raveendra Pai, who contribute to the collaborative efforts in developing advanced pharmaceutical solutions.

Conclusion

Jitendra Patil's contributions to the field of respiratory treatment through his innovative inventions highlight his commitment to improving healthcare. His work exemplifies the impact of dedicated inventors in advancing medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…